Fertility and Miscarriage Incidence After Cervical Intraepithelial Neoplasia Treatment by Thermal Ablation: A Cohort Study

Overview

Journal BJOG

Specialty Gynecology & Obstetrics

Date 2024 Sep 16

PMID 39279637

Authors

Ania Wisniak

Virginie Yakam

Sophie Evina Bolo

Alida Moukam

Jessica Sormani

Pierre Vassilakos

Bruno Kenfack

Patrick Petignat

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the impact of thermal ablation (TA) for the treatment of cervical dysplasia on fertility and pregnancy outcomes among women screened for cervical cancer in Cameroon.

Design: Retrospective cohort study.

Setting: Dschang health district, Cameroon.

Population: Participants aged 30-45 years from two screening trials conducted between 2015 and 2020 in Dschang District Hospital.

Methods: Participants were primarily screened for human papillomavirus infection, triaged by visual inspection and treated by TA if needed. Between October 2021 and March 2022, interviews on subsequent fertility were conducted with participants treated by TA and a control group of untreated women.

Main Outcome Measures: Pregnancy and miscarriage after screening/treatment.

Results: A total of 760 participants (219 treated and 541 untreated) completed the survey, with a mean follow-up time of 1297 days. Sixty-two women (28.3%) treated by TA reported a pregnancy postscreening versus 165 (30.5%) in the control group (p = 0.550). Adjusted for potential confounders, the hazard ratio of pregnancy for treated compared with untreated women was 0.82 (0.54-1.24, p = 0.350). Among women reporting pregnancies with a known outcome and which were not voluntarily terminated, 18 (35.3%) treated participants had a miscarriage versus 31 (21.4%) in the control group (p = 0.048). In the adjusted model, no association remained between TA and miscarriage (1.04, 0.39-2.78, p = 0.935).

Conclusions: In our study population, TA did not significantly impact fertility nor miscarriage risk. Our results support the widespread use of TA as a treatment of choice for precancerous cervical lesions in low-income settings.

References

Sauvaget C, Bazikamwe S, Lucas E, Ndayikengurukiye A, Harerimana S, Barango P . Evaluation of effectiveness, acceptability and safety of thermal ablation in the treatment of cervical neoplasia in Burundi. Int J Cancer. 2022; 151(7):1120-1126. DOI: 10.1002/ijc.34117. View

Chigbu C, Aniebue U . Non-uptake of colposcopy in a resource-poor setting. Int J Gynaecol Obstet. 2011; 113(2):100-2. DOI: 10.1016/j.ijgo.2010.11.017. View

Petignat P, Kenfack B, Wisniak A, Saiji E, Tille J, Tsuala Fouogue J . ABCD criteria to improve visual inspection with acetic acid (VIA) triage in HPV-positive women: a prospective study of diagnostic accuracy. BMJ Open. 2022; 12(4):e052504. PMC: 8981272. DOI: 10.1136/bmjopen-2021-052504. View

Naleway A, Weinmann S, Krishnarajah G, Arondekar B, Fernandez J, Swamy G . Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort. PLoS One. 2015; 10(2):e0117525. PMC: 4324989. DOI: 10.1371/journal.pone.0117525. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Pinder L, Parham G, Basu P, Muwonge R, Lucas E, Nyambe N . Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2019; 21(1):175-184. PMC: 6946855. DOI: 10.1016/S1470-2045(19)30635-7. View

Gordon H, Duncan I . Effective destruction of cervical intraepithelial neoplasia (CIN) 3 at 100 degrees C using the Semm cold coagulator: 14 years experience. Br J Obstet Gynaecol. 1991; 98(1):14-20. DOI: 10.1111/j.1471-0528.1991.tb10304.x. View

Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch F . Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016; 4(7):e453-63. DOI: 10.1016/S2214-109X(16)30099-7. View

Lunsford N, Ragan K, Smith J, Saraiya M, Aketch M . Environmental and Psychosocial Barriers to and Benefits of Cervical Cancer Screening in Kenya. Oncologist. 2017; 22(2):173-181. PMC: 5330703. DOI: 10.1634/theoncologist.2016-0213. View

10.

Hammond R, Edmonds D . Does treatment for cervical intraepithelial neoplasia affect fertility and pregnancy?. BMJ. 1990; 301(6765):1344-5. PMC: 1664508. DOI: 10.1136/bmj.301.6765.1344. View

11.

Spitzer M, Herman J, Krumholz B, Lesser M . The fertility of women after cervical laser surgery. Obstet Gynecol. 1995; 86(4 Pt 1):504-8. DOI: 10.1016/0029-7844(95)00237-l. View

12.

Spracklen C, Harland K, Stegmann B, Saftlas A . Cervical surgery for cervical intraepithelial neoplasia and prolonged time to conception of a live birth: a case-control study. BJOG. 2013; 120(8):960-5. PMC: 3691952. DOI: 10.1111/1471-0528.12209. View

13.

Wise L, Willis S, Perkins R, Wesselink A, Klann A, Crowe H . A prospective study of treatments for cervical intraepithelial neoplasia and fecundability. Am J Obstet Gynecol. 2019; 223(1):96.e1-96.e15. PMC: 8041134. DOI: 10.1016/j.ajog.2019.12.017. View

14.

Randall T, Sauvaget C, Muwonge R, Trimble E, Jeronimo J . Worthy of further consideration: An updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions. Prev Med. 2018; 118:81-91. DOI: 10.1016/j.ypmed.2018.10.006. View

15.

Kalliala I, Anttila A, Dyba T, Hakulinen T, Halttunen M, Nieminen P . Pregnancy incidence and outcome among patients with cervical intraepithelial neoplasia: a retrospective cohort study. BJOG. 2011; 119(2):227-35. DOI: 10.1111/j.1471-0528.2011.03042.x. View

16.

Zhuang H, Hong S, Zheng L, Zhang L, Zhuang X, Wei H . Effects of cervical conisation on pregnancy outcome: a meta-analysis. J Obstet Gynaecol. 2018; 39(1):74-81. DOI: 10.1080/01443615.2018.1463206. View

17.

Broquet C, Vassilakos P, Ndam Nsangou F, Kenfack B, Noubom M, Tincho E . Utility of extended HPV genotyping for the triage of self-sampled HPV-positive women in a screen-and-treat strategy for cervical cancer prevention in Cameroon: a prospective study of diagnostic accuracy. BMJ Open. 2022; 12(12):e057234. PMC: 9791451. DOI: 10.1136/bmjopen-2021-057234. View

18.

Papoutsis D, Underwood M, Parry-Smith W, Panikkar J . Early and late pregnancy outcomes in women treated with cold-coagulation versus LLETZ cervical treatment for cervical intraepithelial neoplasia; a retrospective cohort study. Arch Gynecol Obstet. 2018; 297(4):1015-1025. DOI: 10.1007/s00404-018-4704-x. View

19.

Levy J, de Preux M, Kenfack B, Sormani J, Catarino R, Tincho E . Implementing the 3T-approach for cervical cancer screening in Cameroon: Preliminary results on program performance. Cancer Med. 2020; 9(19):7293-7300. PMC: 7541141. DOI: 10.1002/cam4.3355. View

20.

Kunckler M, Schumacher F, Kenfack B, Catarino R, Viviano M, Tincho E . Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach. Cancer Med. 2017; 6(7):1752-1761. PMC: 5504339. DOI: 10.1002/cam4.1089. View